Latest Motor neuron disease Stories
Spinal muscular atrophy (SMA) is the most frequently inherited cause of infant mortality.
NASHVILLE, Tenn., June 29, 2011 /PRNewswire-USNewswire/ -- The Olive Branch Fund: A Thisbe and Noah Scott Legacy, an organization dedicated to combating pediatric motor neuron diseases, today announced its first funding award to Kevin Eggan, Ph.D., Associate Professor of Stem Cell and Regenerative Biology at Harvard University.
ANN ARBOR, Mich., June 23, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc.
An international team of scientists led by researchers at the University of California, San Diego School of Medicine have used induced pluripotent stem cells (iPSCs) derived from patients with amyotrophic lateral sclerosis (ALS) to reveal for the first time how reduced levels of a specific protein may play a central role in causing at least one inherited form of the disease.
The ALS Association Rocky Mountain Chapter is proud to announce that Chuck La Rue, aka â€œChuck Walkingâ€, will take the final steps in his 3,000+ mile walk across the country at the Santa Monica Pier on Sunday, June 12. Santa Monica, CA (PRWEB) June 10, 2011 The ALS Association Rocky Mountain Chapter is proud to announce that Chuck La Rue, aka â€œChuck Walkingâ€, will take the final steps in his 3,000+ mile walk across the country at the Santa Monica Pier on Sunday, June...
Augie Nieto, ALS Patient and Fitness Pioneer also to be Recognized CAMBRIDGE, Mass., June 7, 2011 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it will present Congressman Michael Capuano (D-MA) with its first ever "Lou Gehrig Award" during its annual A White Coat Affair gala event this November 3rd.
Failure in nerve-fiber navigation corrected in zebrafish model; suggests possibility of a drug treatment BOSTON, June 6, 2011 /PRNewswire-USNewswire/ -- Spinal muscular atrophy (SMA) is the leading genetic cause of death in children under 2, with no treatment other than supportive care.
CAMBRIDGE, Mass., June 6, 2011 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today the agenda for its 7th annual Leadership Summit to be held in Cambridge on November 4th, 2011.
WOONSOCKET, R.I., June 6, 2011 /PRNewswire/ -- On June 5, CVS/pharmacy kicked-off its 10th annual in-store fundraising campaign -- "Researching a Cure" -- to support the fight against amyotrophic lateral sclerosis (ALS).
First ever clinical trial approved for SMA with a novel drug specifically designed to treat the disease CHICAGO, May 19, 2011 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy announced today that Repligen Corporation has received approval from the U.S.
- Emitting flashes of light; glittering.